Jump to content

Stephen Globus

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by ShadyCrack (talk | contribs) at 04:18, 4 August 2022 (Extra space removed). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Stephen Globus is a New York City venture capitalist who is third generation from a prominent banking family. He is currently a founder and director of China Biopharmaceuticals Holdings, which is a major medical company in China. He was a founding shareholder of Genitope Corporation which is a San Francisco-area biotechnology company that designs custom treatments for cancer, including a vaccine to treat lymphoma.

Globus also was founder and chairman of PlasmaCo[1] which developed color plasma television and sold to Osaka based Matsushita (Panasonic) in 1996. Globus was on the Japanese Board of Directors for the proceeding 7 years after the sale. His other ventures activities include key investment or managerial roles in Proscure (sold to Repligen), ExSar, Kimeragen which sold to a Paris-based company whose board Globus served on, Energy Research (Fuel Cell Energy), Nematron, and Tinsley Laboratories which developed the optic correction for Hubble Space Telescope now a division of the Dutch company ASML.

Globus holds patents on panoramic cameras called the Globuscope and optics. Globus is a founder of Globus Studios in Central Manhattan. He is patron of the arts with associations such as Japan Society of New York and China Institute in America.

References

[edit]
  1. ^ Tiwari, Ashutosh (2012-02-21). Intelligent Nanomaterials. John Wiley & Sons. pp. 92–. ISBN 9781118311967. Retrieved 5 July 2012.